CombinedX (CX) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Revenue for Q1 2025 reached 239.2 MSEK, up 6.5% year-over-year, with organic growth at -4.9% due to strategic divestments and market headwinds.
Adjusted EBITA was 27.3 MSEK, nearly flat compared to last year, with a margin of 11.4%.
Strategic divestment and restructuring, including Aspire's Borlänge operations and merger with Ninetech, led to lower growth but preserved profitability.
Workforce reduced to 528 from 606, reflecting restructuring and lower recruitment.
Cash flow from operations decreased to 16.1 MSEK from 31.9 MSEK year-over-year.
Financial highlights
Calendar-adjusted growth was 7.8%, with organic calendar-adjusted growth at -3.5%.
Rolling 12-month (LTM) revenue was 944.4 MSEK, with LTM adjusted EBITA at 81.1 MSEK and margin at 8.6%.
EBITDA rose to 34.8 MSEK (30.9 MSEK), with a margin of 14.5% (13.8%).
Revenue per employee (LTM) increased to 1,720 KSEK; personnel cost per FTE LTM rose 8.8% to 1,089 KSEK.
Net result for the period was 17.3 MSEK, nearly unchanged year-over-year.
Outlook and guidance
Focus remains on maintaining healthy profitability amid a cautious market, with growth targeted through acquisitions.
The company aims for adjusted EBITA margin of at least 12% LTM and revenue of at least 1 billion SEK by 2025.
Management sees good prospects despite a cautious market and does not provide forecasts.
Latest events from CombinedX
- Record revenue, margin gains, and acquisitions drive a strategic shift to specialist brands.CX
Q4 202511 Feb 2026 - Strong revenue growth offset by sharply lower margins amid integration and market challenges.CX
Q2 202428 Jan 2026 - Q3 2025 saw higher margins and revenue, driven by acquisitions despite negative organic growth.CX
Q3 202524 Oct 2025 - Revenue declined and margins improved, with acquisitions supporting strategic growth.CX
Q2 202517 Jul 2025 - Sales up 27.5% but margins and organic growth fell; restructuring targets improved 2025 results.CX
Q3 202413 Jun 2025 - Revenue surged but organic growth and margins fell; acquisitions set up 2025 recovery.CX
Q4 20245 Jun 2025